Baillie Gifford acquired 732 Thousand Twist Bioscience shares worth $23.9 Million. That's 0.02% of their equity portfolio (165th largest holding). The investor owns 1.02% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q3 2022. Since then Baillie Gifford bought shares three more times and sold shares on seven occasions. The investor's estimated purchase price is $26.6 Million, resulting in a loss of 10%.